Your browser doesn't support javascript.
loading
Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls.
Amant, Frédéric; Nekljudova, Valentina; Maggen, Charlotte; Seither, Fenja; Neven, Patrick; Cardonick, Elyce H; Schmatloch, Sabine; Van Calsteren, Kristel; Cordes, Tatjana; de Haan, Jorine; Lok, Christianne A R; Flock, Felix; Boere, Ingrid A; Gziri, Mina M; Solbach, Christine; Lefrère, Hanne; Schneeweiss, Andreas; Witzel, Isabell; Seiler, Sabine; Loibl, Sibylle.
Afiliación
  • Amant F; Department of Oncology, KU Leuven, Leuven, Belgium; Department of Gynecologic Oncology, Centre for Gynecologic Oncology Amsterdam, Amsterdam University Medical Centers, Netherlands; Department of Gynecologic Oncology, Centre for Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek - Netherlands Ca
  • Nekljudova V; German Breast Group, Neu-Isenburg, Germany.
  • Maggen C; Department of Oncology, KU Leuven, Leuven, Belgium; Department of Obstetrics and Prenatal Medicine, Vrije Universiteit Brussel (VUB), University Hospital of Brussels, Brussels, Belgium.
  • Seither F; German Breast Group, Neu-Isenburg, Germany.
  • Neven P; Multidisciplinary Breast Center, Universitair Ziekenhuis, Leuven, Belgium.
  • Cardonick EH; Department of Obstetrics and Gynecology, Cooper University Health Care, Camden, NJ, USA.
  • Schmatloch S; Elisabeth Krankenhaus Kassel, Germany.
  • Van Calsteren K; Department of Development and Regeneration, KU Leuven, Leuven, Belgium, Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
  • Cordes T; HSK Wiesbaden, Germany.
  • de Haan J; Department of Obstetrics and Gynecology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Lok CAR; Department of Gynecologic Oncology, Centre for Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Flock F; Department of Obstetrics and Gynecology, Klinikum Memmingen, Germany.
  • Boere IA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, Netherlands.
  • Gziri MM; Department of Obstetrics, Cliniques Universitaires St Luc, UCL, Sint-Lambrechts-Woluwe, Belgium.
  • Solbach C; Goethe Universität Frankfurt, Germany.
  • Lefrère H; Department of Oncology, KU Leuven, Leuven, Belgium.
  • Schneeweiss A; Nationales Centrum für Tumourerkrankungen, Heidelberg, Germany.
  • Witzel I; Department of Gynecology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Seiler S; German Breast Group, Neu-Isenburg, Germany.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
Eur J Cancer ; 170: 54-63, 2022 07.
Article en En | MEDLINE | ID: mdl-35594612
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido